AtriCure (NASDAQ:ATRC) Raised to “Buy” at Wall Street Zen
2 Articles
2 Articles
AtriCure (NASDAQ:ATRC) Raised to “Buy” at Wall Street Zen
Wall Street Zen upgraded shares of AtriCure (NASDAQ:ATRC – Free Report) from a hold rating to a buy rating in a research report report published on Saturday morning. Other equities analysts also recently issued reports about the company. Needham & Company LLC decreased their target price on AtriCure from $51.00 to $44.00 and set a […]
AtriCure (NASDAQ:ATRC) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of AtriCure (NASDAQ:ATRC – Free Report) from a hold rating to a buy rating in a research report sent to investors on Saturday morning. ATRC has been the subject of a number of other reports. JMP Securities reissued a “market outperform” rating and set a $60.00 price target on shares […]
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage